Anjiang formula inhibits PVN microglial activation and lowers blood pressure by targeting RhoA/ROCK2 pathway: a retrospective clinical and experimental study.

Front Pharmacol · 2026 · PMC12960113 · PMID 41800080

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

While cIMT and cardiac remodeling indices (LVMI, E/e') showed favorable downward trends, these structural changes did not reach statistical significance over the 8-week period ( p > 0.05; Figures 2d–g ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.